Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 30, 2026 1.050
October 29, 2026 1.014
October 28, 2026 1.072
October 27, 2026 1.058
October 26, 2026 0.9768
October 23, 2026 0.9107
October 22, 2026 0.94
October 21, 2026 0.9254
October 20, 2026 0.9107
October 19, 2026 1.006
October 16, 2026 0.8813
October 15, 2026 0.8299
October 14, 2026 0.8519
October 13, 2026 0.8813
October 12, 2026 0.9694
October 09, 2026 1.021
October 08, 2026 0.94
October 07, 2026 1.028
October 06, 2026 1.058
October 05, 2026 1.058
October 02, 2026 1.072
October 01, 2026 1.080
September 30, 2026 1.116
September 29, 2026 1.131
September 28, 2026 1.131
Date Value
September 25, 2026 1.179
September 24, 2026 1.182
September 23, 2026 1.197
September 22, 2026 1.197
September 21, 2026 1.197
September 18, 2026 1.182
September 17, 2026 1.307
September 16, 2026 1.263
September 15, 2026 1.285
September 14, 2026 1.506
September 11, 2026 1.417
September 10, 2026 1.403
September 09, 2026 1.447
September 08, 2026 1.520
September 04, 2026 1.469
September 03, 2026 1.491
September 02, 2026 1.491
September 01, 2026 1.645
August 31, 2026 1.674
August 28, 2026 1.586
August 27, 2026 1.608
August 26, 2026 1.550
August 25, 2026 1.535
August 24, 2026 1.572
August 21, 2026 1.432

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 21.55
Anika Therapeutics, Inc. 2.042
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.014

Price to Book Value Related Metrics

Price 1.43
Earnings Yield -223.6%
Market Cap 10.79M